tosufloxacin has been researched along with Bacterial Pneumonia in 4 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishima, N | 1 |
| Komiya, K | 1 |
| Matsunaga, N | 1 |
| Usagawa, Y | 1 |
| Yamasue, M | 1 |
| Hashinaga, K | 1 |
| Umeki, K | 1 |
| Nureki, SI | 1 |
| Ando, M | 1 |
| Matsunaga, T | 1 |
| Kadota, JI | 1 |
| Sunakawa, K | 1 |
| Masuda, N | 1 |
| Takahashi, Y | 1 |
| Otsuki, M | 1 |
| Ibuki, E | 1 |
| Miyoshi, H | 1 |
| Nishino, T | 1 |
| Kohno, S | 1 |
1 review available for tosufloxacin and Bacterial Pneumonia
| Article | Year |
|---|---|
Clinical assessment of tosufloxacin tosilate.
Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Microbial Sensitivit | 2002 |
3 other studies available for tosufloxacin and Bacterial Pneumonia
| Article | Year |
|---|---|
A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluoroquinolones; Humans; Male; Mycobacterium tuberculos | 2019 |
[Intractable pediatric infectious disease: examining the ability of a new drug, tosufloxacin tosilate hydrate for pediatric].
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Naphthyridines; | 2010 |
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; F | 1996 |